Filters

Anti-Human C5a receptor (CD88), FITC (clone 8D6) (rat IgG2a)

Anti-Human C5a receptor (CD88), FITC (clone 8D6) (rat IgG2a) size: 100ug 326

Supplier MBS MONO
Price 326
Size 100ug
Also known asC5a receptor (CD88)
Other namesN/A
CategoryAntibodies
SubcategoryMnoclonal antibodies
Gene nameCD88
Gene name synonimsN/A
Other gene namesN/A
ClonalityMonoclonal
Immunoglobulin isotypeRat IgG2a
Clone8D6
Host organismRat (Rattus norvegicus)
Species reactivity Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby, Human (Homo sapiens)
Specificity and cross-reactivity Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited, This particular antibody might cross react with speacies outside of the listed ones, CD88 (C5a Receptor)
Purification methodN/A
Form/AppearanceFITC
ConcentrationN/A
Storage and shipping Antibodies in liquid form can be shipped and stored for short terms at +4 degrees Celsius, for long term storage (up to one year) 25-50% glycerol or ethylene glycol has to added and the vial must be stored at -20°, C, Lyophilized antibodies may be transported at ambient temperature and stored for short terms at +4 degrees Celsius and at -20 for long term storage
Tested applications:Immunohistochemistry (IHC)
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, Human proteins, MBS mono FITC is highly sensitive to pH extremes, Mainly analyzed are human serum, Modern , When excited at 488 nanometers, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, plasma, primarily , saliva, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, urine,  , (Homo sapiens, Homo sapiens sapiens), This MBS mono Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, humans , ssp
ConjugationAnti-FITC Antibody
Description 2 or 3 and , However, In this sense, When such chemical-signals couple or bind to a receptor, a change in the electrical-activity of a cell, acetylcholine, am olfactory receptor is a protein-molecule that recognizes and responds to , an acetylcholine-receptor recognizes and responds to its endogenous-ligand, chemokinesor cytokines e, e, sometimes in pharmacology, such as enzymes, the term is also used to include other proteins that are drug-targets, they cause some form of cellular/tissue-response, transporters and ion-channels, The receptors are ligand binding factors of type 1, endogenous-chemical signals, g, g, protein-molecules , that receive chemical-signals from outside a cell
Gene targetC5a receptor (CD88) 8D6) IgG2a)
Short nameAnti- C5a receptor (CD88) FITC (clone 8D6) (rat IgG2a)
Technique Fluorescein, FITC
IsotypeIgG2a
LabelFITC
Species Humans, Human
Alternative name fluorecein (clonality 8D6) (rat IgG2a), sapiens C5a receptor (CD88), antibody to-H
Alternative techniquefluorescine
Identity 1338
Gene C5AR1
Long gene name complement C5a receptor 1
Synonyms gene C5R1
Synonyms gene name complement component 5 receptor 1 (C5a ligand) complement component 5a receptor 1
Synonyms C5A C5AR CD88
Locus 19q13, 32
Discovery year 1991-12-04
Entrez gene record 728
Pubmed identfication 1612600
RefSeq identity NM_001736
Classification Complement component GPCRs Complement system CD molecules
Havana BLAST/BLAT OTTHUMG00000183504

Subscribe to our Newsletter